Drug Testing Locations - Franklin, MI

Drug Testing in Franklin, MI

Franklin, Michigan Statistics

In Franklin, MI, located in Oakland County, overdoses have increased by 15% over the past three years.

Franklin, Michigan, in Oakland County, has seen a 10% rise in drug-related arrests over the last year.

Opioid prescriptions in Franklin, MI have decreased by 17% since a state mandate for prescription monitoring.

Oakland County, which includes Franklin, reports a 5% increase in drug rehabilitation program enrollment.

Franklin, MI, part of Oakland County, has expanded substance abuse education in schools by 20% since 2019.

Community surveys in Franklin, MI from Oakland County indicate that 30% of residents view drug abuse as a significant local issue.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Franklin, MI & Drug Testing Policies

Employers in Franklin, MI are increasingly incorporating stringent drug testing policies to maintain workplace safety. Many companies in Oakland County require pre-employment and random drug screenings to deter substance misuse among employees. This aligns with state-wide efforts to ensure a drug-free work environment supported by the Michigan Department of Labor and Economic Opportunity.

In Franklin, the workplace drug policies are designed to not only identify but also support employees struggling with addiction through employee assistance programs. These policies often reflect broader state regulations outlined by the Michigan Department of Health and Human Services, focusing on rehabilitation as much as prevention.

Government Efforts with Drug Problems in Franklin, MI

The government of Franklin, MI, located in Oakland County, is actively working to address drug issues through various initiatives. The Oakland County Health Division offers educational programs and resources to prevent drug misuse. Additionally, state-level efforts such as the Michigan Prescription Drug and Opioid Abuse Task Force aim to reduce substance abuse across the region.

Franklin's local police department collaborates with the Michigan Department of Health and Human Services to provide support for those struggling with addiction. The city also takes part in substance abuse awareness campaigns to educate residents about the risks and available support systems.

Local Drug Busts & News in Franklin, MI

Over the past year, Franklin, MI has seen several notable drug-related events, highlighting ongoing substance abuse challenges in Oakland County. Local police have conducted multiple drug bust operations, leading to significant arrests and seizures of illegal substances.

These efforts form part of a larger strategy to tackle drug crime throughout the area, collaborating closely with state and federal law enforcement agencies. Such events underscore the importance of continuous vigilance and community involvement in combating drug issues in Franklin.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Franklin, MI. Trusted by employers nationwide for accurate results and exceptional service.

Michigan DOT/Non DOT Physicals

Michigan Vision Tests

Michigan Audiograms

Michigan Respirator Fit Tests

Michigan Lift Tests

Michigan Background Checks

Clinical Testing Services

TB Testing in MI

Diabetes Testing in MI

Infectious Disease Testing in MI

Sickle Cell Anemia Testing in MI

Women/Men's Health Testing in MI

Resources & Citations

Oakland County Health Division

MDHHS - Substance Use Information

Michigan o-drugs

DrugRehab.com - Michigan

Michigan Substance Abuse Prevention

DrugAbuse.com - Michigan

CADCA

Partnership for Addiction Care - MI

Drug Testing Near Franklin, MI

Farmington, MI

West Bloomfield Township, MI

Orchard Lake Village, MI

Southfield, MI

Birmingham, MI

Bloomfield Hills, MI

Farmington Hills, MI

Orchard Lake, MI

Bloomfield Township, MI

Lathrup Village, MI

Beverly Hills, MI

Bingham Farms, MI

Frequently Asked Questions

Customer Reviews